good post pedromm !!!!!!
Recent PHARM News
- Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older • GlobeNewswire Inc. • 03/27/2026 06:00:00 AM
- Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older • GlobeNewswire Inc. • 03/24/2026 06:00:00 AM
- Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow • GlobeNewswire Inc. • 03/12/2026 06:00:00 AM
- Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day • GlobeNewswire Inc. • 02/03/2026 06:00:00 AM
- Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS • GlobeNewswire Inc. • 02/01/2026 08:17:00 PM
- DAX, CAC, FTSE100, European equities drift lower amid U.S.–Venezuela tensions and data watch • UK Market News • 01/08/2026 02:17:15 PM
- Pharming Group reports preliminary 2025 revenues and announces Investor Day • GlobeNewswire Inc. • 01/08/2026 06:00:00 AM
- Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow • GlobeNewswire Inc. • 11/06/2025 06:00:00 AM
- Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio • GlobeNewswire Inc. • 10/20/2025 06:00:33 AM
- Pharming Group provides update on previously announced G&A expense reduction plan • GlobeNewswire Inc. • 10/06/2025 03:35:57 PM
- Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years • GlobeNewswire Inc. • 10/01/2025 05:00:25 AM
- Pharming Group promoted to the Euronext AMX® index • GlobeNewswire Inc. • 09/10/2025 05:00:00 AM
- Pharming Group appoints Kenneth Lynard as Chief Financial Officer • GlobeNewswire Inc. • 09/02/2025 05:00:00 AM
- Pharming Group reports second quarter and first half 2025 financial results and provides business update • GlobeNewswire Inc. • 07/31/2025 05:00:00 AM
- Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis • GlobeNewswire Inc. • 06/24/2025 05:00:00 AM
- Pharming Group reports first quarter 2025 financial results and provides business update • GlobeNewswire Inc. • 05/08/2025 05:00:00 AM
- Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS) • GlobeNewswire Inc. • 04/25/2025 01:00:00 PM
- Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS • GlobeNewswire Inc. • 04/23/2025 07:30:00 AM
